PFP@PLGA/Cu(12)Sb(4)S(13)-mediated PTT ablates hepatocellular carcinoma by inhibiting the RAS/MAPK/MT-CO1 signaling pathway

Hepatocellular carcinoma (HCC) is one of the most malignant tumors in the world, and patients with HCC face a poor prognosis. The conventional therapeutic strategies for HCC have undergone a challenge-riddled evolution owing to side effects and unsatisfactory efficacy. Here, aiming to provide a new...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Tianxiu, Jiang, Jian, Zhang, Hao, Liu, Hongyuan, Zou, Xiaomeng, Niu, Jiamei, Mao, Yingxuan, Zhu, Mingwei, Chen, Xi, Li, Zizhuo, Chen, Yaodong, Shi, Chunying, Yang, Xiuhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Full Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8490557/
https://www.ncbi.nlm.nih.gov/pubmed/34606010
http://dx.doi.org/10.1186/s40580-021-00279-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8490557/
https://www.ncbi.nlm.nih.gov/pubmed/34606010
http://dx.doi.org/10.1186/s40580-021-00279-2

Ejemplares similares